Stay informed with the latest litigation news. Explore now

IP Verse

Antibody Fc Variants - EP2691417B2

EP2691417

ROCHE GLYCART
Application Number
EP12710732A
Filing Date
Mar 27, 2012
Status
Patent Maintained As Amended
Sep 27, 2024
Grant Date
Oct 30, 2024
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2691417B2 was granted to Roche Glycart on Oct 30, 2024 following the initial filing on Mar 27, 2012 under the application number EP12710732A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK PATENTMay 2, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents